AI-Based Microbiome Platforms Market Size, Revenue, Forecast Report 2026 to 2035
Segmentations of AI-Based Microbiome Platforms Market :
AI-Based Microbiome Platforms Market by Microbiome Type-
- Gut Microbiome
- Skin Microbiome
- Oral Microbiome
- Environment Microbiome
AI-Based Microbiome Platforms Market by Deployment Mode-
- Cloud
- On-premises
- Hybrid Models
AI-Based Microbiome Platforms Market by Application-
- Drug Discovery & Development
- Clinical Diagnostics
- Precision Medicine & Personalized Nutrition
- Consumer Microbiome & Wellness Platform
- Others
AI-Based Microbiome Platforms Market by End-user-
- Pharma & Biotechnology Companies
- Clinical & Diagnostic Laboratories
- Resraech & Academic Institutes
- Food & Nutrition Companies
- Others
AI-Based Microbiome Platforms Market By Region-
- North America-
- The US
- Canada
- Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
- Latin America-
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East and Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Scope & Assumptions
Chapter 2 Executive Summary
Chapter 3 Global AI-Based Microbiome Platforms Market Snapshot
Chapter 4 Global AI-Based Microbiome Platforms Market Variables, Trends & Scope
4.1 Market Segmentation & Scope
4.2 Drivers
4.3 Challenges
4.4 Trends
4.5 Investment and Funding Analysis
4.6 Porter's Five Forces Analysis
4.7 Incremental Opportunity Analysis (US$ MN), 2026-2035
4.8 Global AI-Based Microbiome Platforms Market Penetration & Growth Prospect Mapping (US$ Mn), 2025-2035
4.9 Competitive Landscape & Market Share Analysis, By Key Player (2025)
4.10 Use/impact of AI on AI-BASED MICROBIOME PLATFORMS MARKET Industry Trends
Chapter 5 AI-Based Microbiome Platforms Market Segmentation 1: By Microbiome Type, Estimates & Trend Analysis
5.1 Market Share by Microbiome Type, 2025 & 2035
5.2 Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Microbiome Type:
5.2.1 Gut Microbiome
5.2.2 Skin Microbiome
5.2.3 Oral Microbiome
5.2.4 Environmental Microbiome
Chapter 6 AI-Based Microbiome Platforms Market Segmentation 2: By Depolyment Mode, Estimates & Trend Analysis
6.1 Market Share by Depolyment Mode, 2025 & 2035
6.2 Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Depolyment Mode:
6.2.1 Cloud-Based Platforms
6.2.2 On-Premises Platforms
6.2.3 Hybrid Models
Chapter 7 AI-Based Microbiome Platforms Market Segmentation 3: By Application, Estimates & Trend Analysis
7.1 Market Share by Application, 2025 & 2035
7.2 Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Application:
7.2.1 Drug Discovery and Development
7.2.2 Clinical Diagnostics
7.2.3 Precision Medicine and Personalized Nutrition
7.2.4 Consumer Microbiome and Wellness Platforms
7.2.5 Other Applications
Chapter 8 AI-Based Microbiome Platforms Market Segmentation 4: By End-User, Estimates & Trend Analysis
8.1 Market Share by End-User, 2025 & 2035
8.2 Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following End-User:
8.2.1 Pharma and Biotechnology Companies
8.2.2 Clinical and Diagnostic Laboratories
8.2.3 Research and Academic Institutes
8.2.4 Food and Nutrition Companies
8.2.5 Other End-Users
Chapter 9 AI-Based Microbiome Platforms Market Segmentation 5: Regional Estimates & Trend Analysis
9.1 Global AI-Based Microbiome Platforms Market, Regional Snapshot 2025 & 2035
9.2 North America
9.2.1 North America AI-Based Microbiome Platforms Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022-2035
9.2.1.1 The US
9.2.1.2 Canada
9.2.2 North America AI-Based Microbiome Platforms Market Revenue (US$ Million) Estimates and Forecasts by Microbiome Type, 2022-2035
9.2.3 North America AI-Based Microbiome Platforms Market Revenue (US$ Million) Estimates and Forecasts by Depolyment Mode, 2022-2035
9.2.4 North America AI-Based Microbiome Platforms Market Revenue (US$ Million) Estimates and Forecasts by Application, 2022-2035
9.2.5 North America AI-Based Microbiome Platforms Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2022-2035
9.3 Europe
9.3.1 Europe AI-Based Microbiome Platforms Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022-2035
9.3.1.1 Germany
9.3.1.2 The U.K.
9.3.1.3 France
9.3.1.4 Italy
9.3.1.5 Spain
9.3.1.6 Portugal
9.3.1.7 Rest of Europe
9.3.2 Europe AI-Based Microbiome Platforms Market Revenue (US$ Million) Estimates and Forecasts by Microbiome Type, 2022-2035
9.3.3 Europe AI-Based Microbiome Platforms Market Revenue (US$ Million) Estimates and Forecasts by Depolyment Mode, 2022-2035
9.3.4 Europe AI-Based Microbiome Platforms Market Revenue (US$ Million) Estimates and Forecasts by Application, 2022-2035
9.3.5 Europe AI-Based Microbiome Platforms Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2022-2035
9.4 Asia Pacific
9.4.1 Asia Pacific AI-Based Microbiome Platforms Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022-2035
9.4.1.1 India
9.4.1.2 China
9.4.1.3 Japan
9.4.1.4 South Korea
9.4.1.5 Southeast Asia
9.4.1.6 Rest of Asia Pacific
9.4.2 Asia Pacific AI-Based Microbiome Platforms Market Revenue (US$ Million) Estimates and Forecasts by Microbiome Type, 2022-2035
9.4.3 Asia Pacific AI-Based Microbiome Platforms Market Revenue (US$ Million) Estimates and Forecasts by Depolyment Mode, 2022-2035
9.4.4 Asia Pacific AI-Based Microbiome Platforms Market Revenue (US$ Million) Estimates and Forecasts By Application, 2022-2035
9.4.5 Asia Pacific AI-Based Microbiome Platforms Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2022-2035
9.5 Latin America
9.5.1 Latin America AI-Based Microbiome Platforms Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022-2035
9.5.1.1 Brazil
9.5.1.2 Argentina
9.5.1.3 Mexico
9.5.1.4 Colombia
9.5.1.5 Chile
9.5.1.6 Peru
9.5.1.7 Rest of Latin America
9.5.2 Latin America AI-Based Microbiome Platforms Market Revenue (US$ Million) Estimates and Forecasts by Microbiome Type, 2022-2035
9.5.3 Latin America AI-Based Microbiome Platforms Market Revenue (US$ Million) Estimates and Forecasts by Depolyment Mode, 2022-2035
9.5.4 Latin America AI-Based Microbiome Platforms Market Revenue (US$ Million) Estimates and Forecasts by Application, 2022-2035
9.5.5 Latin America AI-Based Microbiome Platforms Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2022-2035
9.6 Middle East & Africa
9.6.1 Middle East & Africa AI-Based Microbiome Platforms Market Revenue (US$ Million) Estimates and Forecasts by country, 2022-2035
9.6.1.1 United Arab Emirates
9.6.1.2 Saudi Arabia
9.6.1.3 South Africa
9.6.1.4 Rest of Middle East and Africa
9.6.2 Middle East & Africa AI-Based Microbiome Platforms Market Revenue (US$ Million) Estimates and Forecasts by Microbiome Type, 2022-2035
9.6.3 Middle East & Africa AI-Based Microbiome Platforms Market Revenue (US$ Million) Estimates and Forecasts by Depolyment Mode, 2022-2035
9.6.4 Middle East & Africa AI-Based Microbiome Platforms Market Revenue (US$ Million) Estimates and Forecasts by Application, 2022-2035
9.6.5 Middle East & Africa AI-Based Microbiome Platforms Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2022-2035
Chapter 10 Competitive Landscape
10.1 Major Mergers and Acquisitions/Strategic Alliances
10.2 Company Profiles
10.2.1 Thermo Fisher Scientific Atlas Biomed
10.2.1.1 Business Overview
10.2.1.2 Key Product/Service
10.2.1.3 Financial Performance
10.2.1.4 Geographical Presence
10.2.1.5 Recent Developments with Business Strategy
10.2.2 Biohm Health
10.2.3 Biome Diagnostics GmbH
10.2.4 BiomeSense
10.2.5 CosmosID
10.2.6 DayTwo
10.2.7 Eagle Genomics
10.2.8 Finch Therapeutics
10.2.9 Ginkgo Bioworks
10.2.10 HelloBiome
10.2.11 Insilico Medicine
10.2.12 Metagenomi
10.2.13 Onegevity (Thorne)
10.2.14 Pendulum Therapeutics
10.2.15 Second Genome
10.2.16 Seed Health
10.2.17 Seer Bio
10.2.18 Sun Genomics
10.2.19 Synlogic
10.2.20 Viome Life Sciences
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
AI-Based Microbiome Platforms Market Size is valued at USD 0.66 Bn in 2025 and is predicted to reach USD 2.23 Bn by the year 2035
The AI-Based Microbiome Platforms Market is expected to grow at a 13.2% CAGR during the forecast period for 2026 to 2035
Viome Life Sciences, Eagle Genomics Ltd., Microba Life Sciences, CosmosID, Second Genome, DayTwo Ltd., Phylagen Inc., Zymo Research Corporation, BaseClear B.V., BiomeSense Inc., QIAGEN N.V., Illumina Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies plc, BioGaia AB, Charles River Laboratories, Eurofins Scientific, Novogene Co., Ltd., Ginkgo Bioworks, Seed Health, Biotia Inc., Resphera Biosciences, DNAnexus, NVIDIA Corporation, Microsoft Corporation, and Google Cloud and Others.
AI-Based Microbiome Platforms Market is segmented into Microbiome Type, Deployment Mode, Application, End-user, and Other.
North America region is leading the AI-Based Microbiome Platforms Market.